Xylem (NYSE:XYL) Stock Breaks Below 50 Day Moving Average After Earnings Miss

Xylem Inc. (NYSE:XYL – Get Free Report) shares crossed below its 50-day moving average during trading on Tuesday following a weaker than expected earnings announcement. The stock has a 50-day moving average of $106.50 and traded as low as $92.61. Xylem shares last traded at $93.1420, with a volume of 10,226,365 shares traded.

The industrial products company reported $1.44 earnings per share for the quarter, missing analysts’ consensus estimates of $1.45 by ($0.01). The firm had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.28 billion. Xylem’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.37 EPS.

Xylem Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 24th. Investors of record on Thursday, August 27th were issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 1.8%. The ex-dividend date was Thursday, August 27th.

Xylem News Roundup

Here are the key news stories impacting Xylem this week:

  • Positive Sentiment: Orders increased 10% year over year, suggesting underlying demand remains healthy despite near-term execution and project-timing issues. Adjusted earnings also rose from the prior-year period to $1.44 per share. Xylem Q3 2026 results
  • Positive Sentiment: Management’s planned portfolio restructuring and cost actions could improve business focus and profitability over time, while infrastructure and data-center demand remain potential longer-term growth drivers.
  • Neutral Sentiment: Management is preparing a portfolio reset and restructuring program. The effort may support future performance, but it could create transition costs and execution risk before benefits emerge. Xylem portfolio reset
  • Negative Sentiment: Third-quarter revenue fell 3% year over year to $2.20 billion, below the approximately $2.28 billion consensus estimate. Earnings of $1.44 per share also missed estimates, reflecting weakness in metering and delayed or softer project activity. Xylem Q3 earnings miss
  • Negative Sentiment: Xylem lowered its 2026 revenue and EPS outlook and issued weaker fourth-quarter expectations, signaling that customer pullbacks, project timing and metering pressure may persist. This guidance reduction was the main reason for the selloff. Xylem lowers 2026 outlook
  • Negative Sentiment: The consensus price target was reduced by 10.52%, reinforcing concerns about weaker near-term earnings and valuation.

Analyst Upgrades and Downgrades

Several research firms have weighed in on XYL. UBS Group dropped their price objective on shares of Xylem from $138.00 to $112.00 and set a “neutral” rating on the stock in a research note on Monday, October 5th. Jefferies Financial Group increased their target price on shares of Xylem from $145.00 to $150.00 and gave the stock a “buy” rating in a research report on Monday, August 24th. JPMorgan Chase & Co. decreased their target price on shares of Xylem from $137.00 to $118.00 and set a “neutral” rating for the company in a research note on Monday, October 19th. Oppenheimer restated an “outperform” rating and set a $150.00 price target (down from $158.00) on shares of Xylem in a report on Wednesday, October 14th. Finally, Stifel Nicolaus set a $141.00 price target on shares of Xylem in a research note on Monday, October 19th. Eight research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat, Xylem presently has a consensus rating of “Moderate Buy” and a consensus target price of $140.85.

View Our Latest Stock Report on XYL

Institutional Investors Weigh In On Xylem

Several large investors have recently made changes to their positions in the company. Oregon Public Employees Retirement Fund increased its holdings in Xylem by 0.4% in the first quarter. Oregon Public Employees Retirement Fund now owns 27,923 shares of the industrial products company’s stock worth $3,337,000 after buying an additional 100 shares during the last quarter. Thrive Wealth Management LLC lifted its stake in Xylem by 2.1% in the second quarter. Thrive Wealth Management LLC now owns 5,032 shares of the industrial products company’s stock valued at $595,000 after acquiring an additional 104 shares during the last quarter. World Investment Advisors lifted its stake in Xylem by 3.7% in the first quarter. World Investment Advisors now owns 3,319 shares of the industrial products company’s stock valued at $397,000 after acquiring an additional 119 shares during the last quarter. Aventus Investment Advisors Inc. grew its position in Xylem by 66.7% in the second quarter. Aventus Investment Advisors Inc. now owns 300 shares of the industrial products company’s stock worth $35,000 after acquiring an additional 120 shares in the last quarter. Finally, Rockland Trust Co. grew its position in Xylem by 3.6% in the third quarter. Rockland Trust Co. now owns 3,582 shares of the industrial products company’s stock worth $363,000 after acquiring an additional 124 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Xylem Price Performance

The company’s 50-day simple moving average is $106.50 and its 200 day simple moving average is $118.31.

Xylem Company Profile

(Get Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.

Further Reading

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.